Consensus Johnson & Johnson

Equities

JNJ

US4781601046

Pharmaceuticals

Market Closed - Nyse Other stock markets 02:30:02 24/01/2026 am IST			5-day change	1st Jan Change
220.14 ^USD	+0.76%		+0.68%	+6.37%

24/01	Argus Raises Price Target on Johnson & Johnson to $240 From $210	MT
23/01	Bernstein Adjusts Price Target on Johnson & Johnson to $225 From $208, Maintains Market Perform Rating	MT

Evolution of the Average Target: Johnson & Johnson

Evolution of the Target Price: Johnson & Johnson

Changes in Analyst Recommendations: Johnson & Johnson

edf.4mgzpfVulkBIqOEVDSbz2_2KBFCDpA8Ap8NjA3TZZ2g.lBJdl41XoQUPkahST0mCk7bCVyfKl01r4LYnckXsBlijMAPsvQv8c3rMtA~090a4526f70aa8871af053e056833d4a

Analysts' recommendations: Johnson & Johnson

24/01	Argus Raises Price Target on Johnson & Johnson to $240 From $210	MT
23/01	Bernstein Adjusts Price Target on Johnson & Johnson to $225 From $208, Maintains Market Perform Rating	MT
23/01	Guggenheim Adjusts Price Target on Johnson & Johnson to $240 From $227, Maintains Buy Rating	MT
22/01	Johnson & Johnson Reports Modest Q4 Beat but Stock Seems Fairly Valued, Morgan Stanley Says	MT
22/01	Goldman Sachs Adjusts Price Target on Johnson & Johnson to $250 From $240, Maintains Buy Rating	MT
22/01	Leerink Partners Adjusts Price Target on Johnson & Johnson to $232 From $201, Maintains Market Perform Rating	MT
22/01	Raymond James Adjusts Price Target on Johnson & Johnson to $237 From $209, Maintains Outperform Rating	MT
22/01	Wolfe Research Adjusts Price Target on Johnson & Johnson to $260 From $240, Maintains Outperform Rating	MT
22/01	Scotiabank Adjusts Price Target on Johnson & Johnson to $265 From $230, Maintains Sector Outperform Rating	MT
22/01	Stifel Adjusts Price Target on Johnson & Johnson to $220 From $205, Maintains Hold Rating	MT
22/01	JPMorgan Adjusts Price Target on Johnson & Johnson to $225 From $205, Maintains Neutral Rating	MT
22/01	Citigroup Adjusts Price Target on Johnson & Johnson to $250 From $232, Maintains Buy Rating	MT
22/01	TD Cowen Adjusts Price Target on Johnson & Johnson to $250 From $222, Maintains Buy Rating	MT
22/01	Morgan Stanley Adjusts Price Target on Johnson & Johnson to $200 From $197, Maintains Equalweight Rating	MT
22/01	Wells Fargo Adjusts Price Target on Johnson & Johnson to $240 From $230, Maintains Overweight Rating	MT
22/01	Morgan Stanley Raises Price Target on Johnson & Johnson to $200 From $197, Keeps Equalweight Rating	MT
09/01	Bernstein Adjusts PT on Johnson & Johnson to $208 From $193, Maintains Market Perform Rating	MT
07/01	Stifel Adjusts Price Target on Johnson & Johnson to $205 From $190, Maintains Hold Rating	MT
05/01	Wolfe Research Adjusts PT on Johnson & Johnson to $240 From $225, Maintains Outperform Rating	MT
30/12	Barclays Adjusts PT on Johnson & Johnson to $217 From $197, Maintains Equalweight Rating	MT
18/12	Goldman Sachs Adjusts Johnson & Johnson Price Target to $240 From $213, Maintains Buy Rating	MT
17/12	RBC Lifts Price Target on Johnson & Johnson to $240 From $230, Maintains Outperform Rating	MT
15/12	Johnson & Johnson Remains Stable With Modest Growth Potential, BofA Says	MT
12/12	Wells Fargo Adjusts Price Target on Johnson & Johnson to $230 From $212, Maintains Overweight Rating	MT
12/12	Morgan Stanley Adjusts PT on Johnson & Johnson to $197 From $190, Maintains Equalweight Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	JOHNSON & JOHNSON					+1.72%
	ELI LILLY AND COMPANY					+2.15%
	ABBVIE INC.					+12.43%
	ROCHE HOLDING AG					-1.62%
	ASTRAZENECA PLC					+11.68%
	NOVARTIS AG					-3.28%
	NOVO NORDISK A/S					+2.09%
	MERCK & CO., INC.					+5.43%
	AMGEN INC.					-4.46%
	GILEAD SCIENCES, INC.					+2.59%
	Average					+2.87%
	Weighted average by Cap.					+3.01%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

220.14USD

Average target price

224.08USD

Spread / Average Target

+1.79%

High Price Target

265.00USD

Spread / Highest target

+20.38%

Low Price Target

155.00USD

Spread / Lowest Target

-29.59%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Bernstein
Guggenheim
JPMorgan Chase
Morgan Stanley
Wells Fargo Securities
TD Cowen
Citigroup
Stifel Nicolaus
Scotiabank
Wolfe Research
Raymond James
Leerink Partners
Goldman Sachs
Barclays
RBC Capital Markets
HSBC
Rothschild & Co Redburn
Daiwa Securities
BofA Securities
Argus
UBS
DBS Bank
Redburn Atlantic
DZ Bank
Atlantic Equities
Credit Suisse
SVB Securities LLC
DA Davidson
SVB Financial
Sanford Bernstein
Cantor Fitzgerald
J.P. Morgan Chase
Cowen
SVB Leerink
RBC	Brandon Henry